Interacciones farmacológicas con el uso de bloqueantes neuromusculares

[1]  M. W. van den Heuvel,et al.  Assessment of the potential for displacement interactions with sugammadex: a pharmacokinetic-pharmacodynamic modelling approach. , 2011, Clinical drug investigation.

[2]  S. Kira.  [Resistance to vecuronium induced muscle relaxation in a patient with mental retardation receiving phenytoin for chronic anticonvulsant therapy]. , 2011, Masui. The Japanese journal of anesthesiology.

[3]  TJ Searl,et al.  Post‐junctional interactions between neuromuscular blocking agents and ethanol at the mouse neuromuscular junction , 2010, British journal of pharmacology.

[4]  H. Sunaga,et al.  Gantacurium and CW002 Do Not Potentiate Muscarinic Receptor-mediated Airway Smooth Muscle Constriction in Guinea Pigs , 2010, Anesthesiology.

[5]  L. Rodrigues-Simioni,et al.  Influence of local anesthetics on the neuromuscular blockade produced by rocuronium: effects of lidocaine and 50% enantiomeric excess bupivacaine on the neuromuscular junction. , 2009, Revista brasileira de anestesiologia.

[6]  M. Mantovani,et al.  Phenobarbital influence on neuromuscular block produced by rocuronium in rats. , 2008, Acta cirurgica brasileira.

[7]  P. Gambús,et al.  Pharmacokinetic–pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery , 2008, European Journal of Clinical Pharmacology.

[8]  A. Braga,et al.  [Influence of lithium on the neuromuscular blockade produced by atracurium and cisatracurium: study on rat phrenic nerve-diaphragm preparations.]. , 2007, Revista brasileira de anestesiologia.

[9]  F. Braga,et al.  [Influence of lidocaine on the neuromuscular block produced by rocuronium: study in rat phrenic-diaphragmatic nerve preparation.]. , 2006, Revista brasileira de anestesiologia.

[10]  A. Braga,et al.  [Influence of nifedipine on the neuromuscular block produced by atracurium and cistracurium: study in rat phrenic-diaphragmatic nerve preparation.]. , 2006, Revista brasileira de anestesiologia.

[11]  N. El Ayass.  Decreased mivacurium infusion rate and delayed neuromuscular recovery after metoclopramide: a randomized double blind placebo‐controlled study , 2005, European journal of anaesthesiology.

[12]  C. B. Tripathi,et al.  Interaction between H2-receptor blocker and neuromuscular blockers in vitro , 2002 .

[13]  D. Greenblatt,et al.  Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. , 2001, British journal of anaesthesia.

[14]  G. Cammu.  Interactions of neuromuscular blocking drugs. , 2001, Acta anaesthesiologica Belgica.

[15]  S. Rasmussen,et al.  The Influence of Drug-induced Low Plasma Cholinesterase Activity on the Pharmacokinetics and Pharmacodynamics of Mivacurium , 2000, Anesthesiology.

[16]  L. Karalliedde,et al.  Drug Interactions with Neuromuscular Blockers , 1996, Drug safety.

[17]  J. Engbaek,et al.  Adverse Reactions and Interactions of the Neuromuscular Blocking Drugs , 1989, Medical toxicology and adverse drug experience.